131 related articles for article (PubMed ID: 12230936)
21. Herpesvirus saimiri transformation of HIV type 1 suppressive CD8+ lymphocytes from an HIV type 1-infected asymptomatic individual.
Lacey SF; Weinhold KJ; Chen CH; McDanal C; Oei C; Greenberg ML
AIDS Res Hum Retroviruses; 1998 Apr; 14(6):521-31. PubMed ID: 9566555
[TBL] [Abstract][Full Text] [Related]
22. Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage.
Cecilia D; KewalRamani VN; O'Leary J; Volsky B; Nyambi P; Burda S; Xu S; Littman DR; Zolla-Pazner S
J Virol; 1998 Sep; 72(9):6988-96. PubMed ID: 9696790
[TBL] [Abstract][Full Text] [Related]
23. Chimeric viruses expressing primary envelope glycoproteins of human immunodeficiency virus type I show increased sensitivity to neutralization by human sera.
McKeating JA; Zhang YJ; Arnold C; Frederiksson R; Fenyö EM; Balfe P
Virology; 1996 Jun; 220(2):450-60. PubMed ID: 8661395
[TBL] [Abstract][Full Text] [Related]
24. Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.
Chakraborty K; Durani V; Miranda ER; Citron M; Liang X; Schleif W; Joyce JG; Varadarajan R
Biochem J; 2006 Nov; 399(3):483-91. PubMed ID: 16827663
[TBL] [Abstract][Full Text] [Related]
25. Recombinant human monoclonal antibody IgG1b12 neutralizes diverse human immunodeficiency virus type 1 primary isolates.
Kessler JA; McKenna PM; Emini EA; Chan CP; Patel MD; Gupta SK; Mark GE; Barbas CF; Burton DR; Conley AJ
AIDS Res Hum Retroviruses; 1997 May; 13(7):575-82. PubMed ID: 9135875
[TBL] [Abstract][Full Text] [Related]
26. V3-specific polyclonal antibodies affinity purified from sera of infected humans effectively neutralize primary isolates of human immunodeficiency virus type 1.
Krachmarov CP; Kayman SC; Honnen WJ; Trochev O; Pinter A
AIDS Res Hum Retroviruses; 2001 Dec; 17(18):1737-48. PubMed ID: 11788025
[TBL] [Abstract][Full Text] [Related]
27. Postattachment neutralization of a primary strain of HIV type 1 in peripheral blood mononuclear cells is mediated by CD4-specific antibodies but not by a glycoprotein 120-specific antibody that gives potent standard neutralization.
McInerney TL; Dimmock NJ
AIDS Res Hum Retroviruses; 2001 Nov; 17(17):1645-54. PubMed ID: 11779352
[TBL] [Abstract][Full Text] [Related]
28. A new cell line-based neutralization assay for primary HIV type 1 isolates.
Shi Y; Albert J; Francis G; Holmes H; Fenyö EM
AIDS Res Hum Retroviruses; 2002 Sep; 18(13):957-67. PubMed ID: 12230938
[TBL] [Abstract][Full Text] [Related]
29. Neutralization of primary human immunodeficiency virus type 1 isolates: a study of parameters implicated in neutralization in vitro.
Moog C; Spenlehauer C; Fleury H; Heshmati F; Saragosti S; Letourneur F; Kirn A; Aubertin AM
AIDS Res Hum Retroviruses; 1997 Jan; 13(1):19-27. PubMed ID: 8989423
[TBL] [Abstract][Full Text] [Related]
30. Role of the V2, V3, and CD4-binding domains of GP120 in curdlan sulfate neutralization sensitivity of HIV-1 during infection of T lymphocytes.
Jagodzinski PP; Wustner J; Kmieciak D; Wasik TJ; Fertala A; Sieron AL; Takahashi M; Tsuji T; Mimura T; Fung MS; Gorny MK; Kloczewiak M; Kaneko Y; Kozbor D
Virology; 1996 Dec; 226(2):217-27. PubMed ID: 8955041
[TBL] [Abstract][Full Text] [Related]
31. Human immunodeficiency virus type 1 (HIV-1) infection of herpesvirus saimiri-immortalized human CD4-positive T lymphoblastoid cells: evidence of enhanced HIV-1 replication and cytopathic effects caused by endogenous interferon-gamma.
Saha K; Caruso M; Volsky DJ
Virology; 1997 Apr; 231(1):1-9. PubMed ID: 9143296
[TBL] [Abstract][Full Text] [Related]
32. Protection of neutralization epitopes in the V3 loop of oligomeric human immunodeficiency virus type 1 glycoprotein 120 by N-linked oligosaccharides in the V1 region.
Losman B; Bolmstedt A; Schønning K; Björndal A ; Westin C; Fenyö EM; Olofsson S
AIDS Res Hum Retroviruses; 2001 Jul; 17(11):1067-76. PubMed ID: 11485624
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the antibody repertoire generated in healthy volunteers following immunization with a monomeric recombinant gp120 construct derived from a CCR5/CXCR4-using human immunodeficiency virus type 1 isolate with sera from naturally infected individuals.
Beddows S; Lister S; Cheingsong R; Bruck C; Weber J
J Virol; 1999 Feb; 73(2):1740-5. PubMed ID: 9882391
[TBL] [Abstract][Full Text] [Related]
34. Strain-Specific V3 and CD4 Binding Site Autologous HIV-1 Neutralizing Antibodies Select Neutralization-Resistant Viruses.
Moody MA; Gao F; Gurley TC; Amos JD; Kumar A; Hora B; Marshall DJ; Whitesides JF; Xia SM; Parks R; Lloyd KE; Hwang KK; Lu X; Bonsignori M; Finzi A; Vandergrift NA; Alam SM; Ferrari G; Shen X; Tomaras GD; Kamanga G; Cohen MS; Sam NE; Kapiga S; Gray ES; Tumba NL; Morris L; Zolla-Pazner S; Gorny MK; Mascola JR; Hahn BH; Shaw GM; Sodroski JG; Liao HX; Montefiori DC; Hraber PT; Korber BT; Haynes BF
Cell Host Microbe; 2015 Sep; 18(3):354-62. PubMed ID: 26355218
[TBL] [Abstract][Full Text] [Related]
35. Development and evaluation of an HIV-1 transfection-neutralization assay.
Back NK; Smit L; Hogervorst E; van Wijk AC; Goudsmit J; Tersmette M
J Acquir Immune Defic Syndr (1988); 1994 Jun; 7(6):531-8. PubMed ID: 7513760
[TBL] [Abstract][Full Text] [Related]
36. Neutralization sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagated.
Sawyer LS; Wrin MT; Crawford-Miksza L; Potts B; Wu Y; Weber PA; Alfonso RD; Hanson CV
J Virol; 1994 Mar; 68(3):1342-9. PubMed ID: 8107199
[TBL] [Abstract][Full Text] [Related]
37. Neutralization titres of HIV-1-specific monoclonal antibodies vary according to the batch of primary human peripheral blood lymphocytes, but do not vary coordinately.
McLain L; Armstrong SJ; Dimmock NJ
J Virol Methods; 1997 Aug; 67(1):69-76. PubMed ID: 9274819
[TBL] [Abstract][Full Text] [Related]
38. Neutralization of primary HIV-1 isolates by anti-envelope monoclonal antibodies.
D'Souza MP; Milman G; Bradac JA; McPhee D; Hanson CV; Hendry RM
AIDS; 1995 Aug; 9(8):867-74. PubMed ID: 7576320
[TBL] [Abstract][Full Text] [Related]
39. A cell line-based neutralization assay for primary human immunodeficiency virus type 1 isolates that use either the CCR5 or the CXCR4 coreceptor.
Trkola A; Matthews J; Gordon C; Ketas T; Moore JP
J Virol; 1999 Nov; 73(11):8966-74. PubMed ID: 10516002
[TBL] [Abstract][Full Text] [Related]
40. Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates.
Sullivan N; Sun Y; Li J; Hofmann W; Sodroski J
J Virol; 1995 Jul; 69(7):4413-22. PubMed ID: 7769703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
